Clinical Trial Update: Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 trial evaluates the safety of dapagliflozin given before surgery in patients with Stage IA lung adenocarcinoma (a form of non-small cell lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Lung Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Lung Adenocarcinoma, Stage IA1 Lung Cancer American Joint Committee on Cancer (AJCC) v8 | EARLY_Phase 1 | Status: RECRUITING